Skip to content
10-Q

Quarterly Report

NURIX THERAPEUTICS, INC. NRIX

0001549595-25-000095

← back to feed
Filed
Jul 9, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Jun 30, 2025 76.45M sh
Shares Diluted Q2 2025 · May 31, 2025 83.88M sh
Shares Diluted Q2 2025 · May 31, 2025 83.72M sh
Shares Diluted Q2 2025 · May 31, 2024 62.38M sh
Shares Diluted Q2 2025 · May 31, 2024 58.66M sh
Capex Q2 2025 · May 31, 2025 $6.16M
Capex Q2 2025 · May 31, 2024 $4.82M
Operating Cash Flow Q2 2025 · May 31, 2025 −$124.25M
Operating Cash Flow Q2 2025 · May 31, 2024 −$81.66M
Cash And Equivalents Q2 2025 · May 31, 2025 $84.26M
Cash And Equivalents Q2 2025 · Nov 30, 2024 $110M
Cash And Equivalents Q2 2025 · May 31, 2024 $116.79M
Stockholders Equity Q2 2025 · May 31, 2025 $447.6M
Stockholders Equity Q2 2025 · Feb 28, 2025 $480.92M
Stockholders Equity Q2 2025 · Nov 30, 2024 $526.99M
Stockholders Equity Q2 2025 · May 31, 2024 $370.69M
Stockholders Equity Q2 2025 · Feb 29, 2024 $168.75M
Stockholders Equity Q2 2025 · Nov 30, 2023 $200.49M
Current Liabilities Q2 2025 · May 31, 2025 $75.61M
Current Liabilities Q2 2025 · Nov 30, 2024 $95.85M
Total Liabilities Q2 2025 · May 31, 2025 $143.95M
Total Liabilities Q2 2025 · Nov 30, 2024 $142.35M
Current Assets Q2 2025 · May 31, 2025 $515.33M
Current Assets Q2 2025 · Nov 30, 2024 $619.39M
Total Assets Q2 2025 · May 31, 2025 $591.56M
Total Assets Q2 2025 · Nov 30, 2024 $669.34M
Eps Diluted Q2 2025 · May 31, 2025 −$0.52
Eps Diluted Q2 2025 · May 31, 2025 −$1.19
Eps Diluted Q2 2025 · May 31, 2024 −$0.71
Eps Diluted Q2 2025 · May 31, 2024 −$1.47
Eps Basic Q2 2025 · May 31, 2025 −$0.52
Eps Basic Q2 2025 · May 31, 2025 −$1.19
Eps Basic Q2 2025 · May 31, 2024 −$0.71
Eps Basic Q2 2025 · May 31, 2024 −$1.47
Sga Expense Q2 2025 · May 31, 2025 $14.28M
Sga Expense Q2 2025 · May 31, 2025 $25.94M
Sga Expense Q2 2025 · May 31, 2024 $11.71M
Sga Expense Q2 2025 · May 31, 2024 $23.51M
Rd Expense Q2 2025 · May 31, 2025 $78.1M
Rd Expense Q2 2025 · May 31, 2025 $147.76M
Rd Expense Q2 2025 · May 31, 2024 $48.92M
Rd Expense Q2 2025 · May 31, 2024 $98.93M
Net Income Q2 2025 · May 31, 2025 −$43.46M
Net Income Q2 2025 · May 31, 2025 −$99.82M
Net Income Q2 2025 · Feb 28, 2025 −$56.35M
Net Income Q2 2025 · May 31, 2024 −$44.55M
Net Income Q2 2025 · May 31, 2024 −$86.06M
Net Income Q2 2025 · Feb 29, 2024 −$41.52M
Operating Income Q2 2025 · May 31, 2025 −$48.32M
Operating Income Q2 2025 · May 31, 2025 −$111.19M
Operating Income Q2 2025 · May 31, 2024 −$48.54M
Operating Income Q2 2025 · May 31, 2024 −$93.76M
Revenue Q2 2025 · May 31, 2025 $44.06M
Revenue Q2 2025 · May 31, 2025 $62.51M
Revenue Q2 2025 · May 31, 2024 $12.09M
Revenue Q2 2025 · May 31, 2024 $28.68M